STELIS BIOPHARMA

Stelis Biopharma is a biopharmaceutical company that delivers affordable treatments to patients in both emerging and developed markets. It provides a one-stop-shop with comprehensive capabilities from Cell line and Process Development through to scale up, cGMP manufacturing, and fills/finish of proteins and peptides. Offer services at every stage of the development life cycle from Pre-Clinical and Clinical Development to Commercial Supply. At Stelis BioSource™, we assure customers of CDMO/CMO ... services, our deep commitment to Quality, Service, and Compliance. Stelis Biopharma Pvt. Ltd. (Stelis) was started in 2013 by Strides Pharma Science Limited (Strides) to drive a global affordable biopharma business. Via on-going investment, Strides remains a majority owner of Stelis alongside GMS Holdings and Tenshi Life Sciences. It continues to operate as an independent and autonomous subsidiary company.More